Stellate Ganglion Block to Treat Long COVID 19 Case Series
Purpose
An assessment of the effectiveness of Stellate Ganglion Block in alleviating symptoms of Long COVID-19.
Conditions
- Long COVID
- Long Covid19
- Post-COVID-19 Syndrome
- Post Acute COVID-19 Syndrome
- Dysautonomia
- Anosmia
- Dysgeusia
- Brain Fog
- Muscle Pain
- Shortness of Breath
- Dizziness
- Fatigue Post Viral
- Cough
- Menstrual Cycle Abnormal
- Pain
Eligibility
- Eligible Ages
- All ages
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
People who scheduled themselves for a SGB in our clinics in Colorado. -
Exclusion Criteria
Stellate Ganglion Block Contraindications -
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
| SGB Patients for Long COVID 19 | Patients who received ultrasound guided Stellate Ganglion block for symptoms of Long COVID in our Colorado clinics. |
|
Recruiting Locations
More Details
- NCT ID
- NCT05812209
- Status
- Completed
- Sponsor
- Metamorphosis LTD
Detailed Description
We evaluated the treatment results of 41 patients (18 male and 23 female) aged between 18 and 89, who received Stellate Ganglion Block (SGB) with Ultrasound guidance for Long COVID-19 Syndrome. The patients were from the United States and received treatment at our Colorado clinics during the period of September to December 2022.Those who responded to our post-procedure follow-up calls were included in the study population.